Tarazepide

DB06435ExperimentalSmall molecule

Investigated for use/treatment in gastrointestinal diseases and disorders (miscellaneous).

Chemical structure of Tarazepide
Primary indication
Investigated for use/treatment in gastrointestinal diseases and disorders (miscellaneous).Curator reviewed
Formula / weight
C28H24N4O2 · 448.526 g/mol (avg)

Resolves to

Compound
UNIIRK2972YZ2UCAS141374-81-4ChEMBLCHEMBL1742455
Structure
InChIKeyCZPILLBHPRAPCB-AREMUKBSSA-NSMILESCN1C2=CC=CC=C2C(=N[C@H](NC(=O)C2=CC3=CC=CC4=C3N2CCC4)C1=O)C1=CC=CC=C1
Targets
P32238CCKAR

What you can answer from here — as of March 06, 2025

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
1+ReferenceStructured and connected to the statements they support
Sign in

Which drugs share a target with Tarazepide, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In